Malignant Esophageal Neoplasm — Trials

Malignant Esophageal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,926 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 518
Recruiting: 301
Ph III recruiting: 41
Growth YoY: +4.1%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.5%
Trials / 1,000 deaths: 32.3 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (169)

clinicaltrialsPublishedShowing 1–23 of 23 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00911092	Predictive Proteomic Factors of the Response to Concomitant Radiochemotherapy in Esophageal Cancer(COL)	completed	Phase 4	50	Centre Oscar LambretOTHER	1	Sep 17, 2026	clinicaltrials
NCT00333099	INEC Study: Immuno-modulating Enteral Nutrition in Cancer	completed	Phase 4	250	University Hospital, Clermont-FerrandOTHER	1	Aug 3, 2026	clinicaltrials